First Week of ICHR March 20th Options Trading

At Ichor Holdings (ICHR) trading $32.24, a $27.50 put bid at $1.15 would obligate purchase at $27.50, effectively setting a cost basis of $26.35 and represents a ~15% OTM put with a 72% probability of expiring worthless; that premium equates to a 4.18% return (31.18% annualized) if it does. On the call side, selling a $35.00 covered call at a $2.40 bid from a $32.24 entry yields 16.00% total return to expiration (Mar 20) if called away, with a 52% chance to expire worthless and a 7.44% premium boost (55.50% annualized). Implied volatilities are elevated (put 101%, call 106%) versus trailing 12‑month volatility of 97%, making these yield‑boosting option strategies attractive but dependent on volatility and downside risk assumptions.

Analysis

Market structure: Short-dated option sellers and yield-focused retail/SMAs are the immediate beneficiaries — selling the $27.50 put nets $1.15 (effective basis $26.35) and selling the $35 call nets $2.40 against a $32.24 stock price. Elevated implied vol (101–106%) vs trailing realized (97%) signals modest vol premium; if IV compresses 10–30% after a benign catalyst, option-seller P/L will be strong but downside assignment risk remains around the 15% OTM put strike.

Risk assessment: Tail risks include an orderbook slowdown or negative guidance (semiconductor capital equipment cyclicality) and geopolitical export controls that could drop ICHR >30% in weeks — assignment and margin spikes are realistic. Near term (to Mar 20) risk is option-expiry gamma (72%/52% expire worthless odds quoted); medium term (3–6 months) depends on orders/earnings cadence; long term (>12 months) ties to semi capex cycle and China demand.

Trade implications: Prefer defined-risk option-selling — e.g., put credit spreads to collect yield while capping downside; covered-call for 16% to Mar 20 is attractive if willing to forgo upside beyond $35. Size tactical exposure small (1–3% NAV total to ICHR strategies), avoid naked puts >1% NAV, and use spreads or collars if IV >100% to limit tail losses.

Contrarian angles: The consensus of “easy yield” from YieldBoost understates assignment friction, financing cost and IV fragility — the 31–55% annualized figures are math artifacts of short expiries, not sustainable returns. Historical semicap cycles show sharp reversals post-earnings; set mechanical stop/roll rules (e.g., close/roll if stock < $25 or IV >150%) to avoid concentrated tail losses.

Key Decisions for Investors

• Sell-to-open a defined-risk put credit spread on ICHR: sell $27.50 / buy $25 Mar 20 (or nearest) with max allocation 1% of NAV per spread; target net credit ≥$0.80 and cap max loss at (strike width - net credit), roll or close if ICHR < $25 or IV >150%.
• If neutral-to-mildly-bullish, buy 100 ICHR shares at ~$32.24 and sell the $35 Mar 20 covered call to lock in ~16% to expiry; size 0.5–1% NAV and close/roll if price > $36 or implied vol rises >20 points to protect against gamma risk.
• Avoid naked short puts >1% NAV given IV>100%; if seeking downside protection buy a put or put calendar: purchase a longer-dated $30 put (3–6 months) or buy a $32/$30 put spread to hedge a long exposure, limit cost to <1% NAV.
• Pair trade (idiosyncratic): if bullish on ICHR vs peers, go long ICHR (or sell puts/spreads) while shorting 0.5x identical dollar exposure of LRCX or SMH to isolate idiosyncratic upside; keep net sector exposure ≤2% NAV and monitor order/revenue prints over next 60 days.